| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 30-Jun-07 | 31-Mar-07 | | Total Revenue | 547,166 | 426,933 | 412,580 | 461,829 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 547,166 | 426,933 | 412,580 | 461,829 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (266,931) | 1,111,208 | 257,397 | 54,342 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | (1,989,572) | 1,989,572 |
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,803,669 | (2,673,847) | 155,183 | 407,487 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,204,916) |
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,598,753 | (2,673,847) | 155,183 | 407,487 | | Interest Expense | 91,368 | 116,937 | (76,867) | 118,247 | | Income Before Tax | 1,507,385 | (2,790,784) | 232,050 | 289,240 | | Income Tax Expense | 684,251 | (1,130,441) | 59,013 | 75,897 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 823,134 | (1,660,343) | 173,037 | 213,343 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 823,134 | (1,660,343) | 173,037 | 213,343 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $823,134 | ($1,660,343) | $173,037 | $213,343 |
|
1.49% Nasdaq 0.00%
Income Statement
